Climate investors are backing Modern Synthesis’ biomaterial technology to reduce emissions and plastic pollution from the fashion, footwear, and automotive industries
Biotechnology specialist, Modern Synthesis has announced the successful closure of a $5.5 million funding round, the proceeds of which will be invested in its microbially-derived, biomaterial manufacturing technology.
Modern Synthesis says the funds will be used to expand production at its pilot facility, enabling to service the increasing number of fashion, footwear, and automotive brands signed up to its waiting list.
Already have an account? Log In




